• World leader in handheld Point of Use testing
• Sensing products for diabetes, coagulation, wine, and water testing
• Developing new products for cancer monitoring and zero alcohol sensors

Universal Biosensors (ASX:UBI) is a world leader in handheld Point of Use testing, with sensing products used to test diabetes and coagulation in blood, chemical properties in wine, and heavy metals in water. The company's products deliver laboratory-grade accuracy and convenience at a fraction of the cost and time of traditional laboratory tests, with a lower carbon footprint. Universal Biosensors has generated billions of dollars in sales from over 15 billion tests delivered to patients and customers worldwide. The company's revenue-generating assets include handheld blood testing for coagulation monitoring, handheld wine testing for various chemical properties, and a veterinary blood testing product for diabetes in cats and dogs. Universal Biosensors is also developing new products, such as a handheld water testing platform for detecting heavy metals, a low/no alcohol sensing device for the wine and beverage industry, and portable testing platforms for prostate, colon, and liver diseases. The company has a world-class manufacturing facility in Australia and a robust intellectual property portfolio, with 42 granted patents across 11 patent families and 21 jurisdictions. Universal Biosensors is actively seeking business partners to expand the global reach of its products.